Miguel Garcia-Gonzalez | Translational Research | Innovative Research Award

Published on by Health Scientists

Dr. Miguel Garcia-Gonzalez | Translational Research | Innovative Research Award

Research group leader | FIDIS/IDIS | Spain

Dr. Miguel García González is a distinguished biomedical researcher and Group Leader at the Instituto de Investigación Sanitaria de Santiago (IDIS/CHUS) in Spain, specializing in Molecular Genetics and Developmental Biology of Kidney Diseases. He earned his Ph.D. in Molecular Biology from the University of Santiago de Compostela, where he developed a strong foundation in genetics, molecular mechanisms, and translational nephrology. His research focuses on understanding the genetic and molecular bases of polycystic kidney disease (PKD) and related hereditary disorders, integrating genomic, cellular, and developmental biology approaches to identify novel therapeutic targets. Dr. García González has authored more than 40 peer-reviewed publications in high-impact journals such as Nature Medicine, PNAS, Kidney International, and Human Molecular Genetics, contributing significantly to the field’s understanding of renal pathophysiology. His work has received numerous national and international research grants and awards, recognizing his excellence in scientific innovation and mentorship. He actively participates in editorial and peer-review roles for several leading journals in nephrology and molecular biology, further influencing the direction of biomedical research. In addition to his research contributions, Dr. García González is deeply committed to training young scientists, supervising doctoral and postdoctoral researchers, and fostering interdisciplinary collaboration across clinical and molecular domains. His pioneering work continues to advance precision medicine approaches in nephrology, bridging basic science discoveries with clinical applications aimed at improving outcomes for patients with genetic kidney diseases. He has 1913 citations from 50 documents with an h-index of 20.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. A comparative proteomic, transcriptomic and glycomic analysis of extracellular vesicle isolation techniques highlights ExoGAG efficiency for a more complete identification of breast milk molecular signaling pathways. (2025). Cell Communication and Signaling.

2. Therapeutic opportunities in polycystic kidney and liver disease through extracellular matrix dynamics. (2025). Biochemical Pharmacology.

3. Characterization of recurrent UMOD variants (p.C255Y and p.Q316P) in a Galician cohort: Genotype–phenotype correlation and clinical implications. (2025). Nefrología.

4. Characterization of the functional component in human milk and identification of the molecular mechanisms undergoing prematurity. (2025). Clinical Nutrition.

5. HNF1B transcription factor: Key regulator in renal physiology and pathogenesis. (2025).

Yang Zhang | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Prof. Dr. Yang Zhang | Clinical Medicine | Best Researcher Award 

Director | Department of Laboratory Medicine Chongqing University | China

Dr. Yang Zhang, Ph.D., currently serves as Director of the Department of Laboratory Medicine at Chongqing University Affiliated Renji Hospital and is an Associate Chief Physician, Postdoctoral Fellow in Clinical Laboratory Diagnostics, and doctoral and master’s supervisor at Chongqing University. She earned her Bachelor of Medicine in Laboratory Medicine (2008), Master of Medicine in Clinical Laboratory Diagnostics (2011), and Ph.D. in Clinical Laboratory Diagnostics (2015) from the Third Military Medical University, complemented by a Ministry of Education-sponsored visiting scholarship at Loma Linda University, USA (2012–2015). Her research centers on precision molecular diagnostics in oncology, with a special focus on POCT rapid diagnostic reagents and spectroscopy-based label-free diagnostic techniques. Dr. Zhang has led multiple high-level research projects, including three funded by the National Natural Science Foundation of China, one by the National Key R&D Program, and numerous provincial and military projects, securing over 6.88 million RMB in funding. She has published more than 40 academic papers as first or corresponding author, with 15 SCI-indexed articles, an H-index of 24, and a single paper cited over 280 times. Her scholarly contributions extend to 12 Chinese invention patents, 1 international PCT patent, and five co-edited scientific monographs, including works on molecular diagnostics and terahertz applications. Dr. Zhang’s achievements have been recognized with numerous honors, such as Chongqing High-Level Young Medical Talent (2022), the “Top Ten Young Scientists in Shapingba District” (2022), First Prize in the Chongqing Association for Science and Technology Innovation (2023), and the National Laboratory Medicine Science and Technology Innovation Award (2021). She also serves as a reviewer for the NSFC and contributes to several national professional committees in laboratory medicine. She has 1044 citations from 43 documents with an h-index of 16.

Profile: Scopus | ORCID 

Publications

1. Zhang, Y. (2020). ENT1 inhibition attenuates apoptosis by activation of cAMP/pCREB/Bcl2 pathway after MCAO in rats. Experimental Neurology, 331, 113362.

2. Zhang, Y. (2020). Identification of immune-related prognostic biomarkers based on the tumor microenvironment in 20 malignant tumor types with poor prognosis. Frontiers in Oncology, 10, 1008.

3. Tian, H., Yuan, C., Liu, Y., Xia, K., Li, M., Xie, F., Chen, Q., Chen, M., Fu, W., & Zhang, Y. (2020, July 28). A sample-to-answer quantification platform for point-of-care testing of circulating microRNAs based on allosteric spherical nanoprobe. Preprint.

4. Zhang, Y. (2020). Evaluation of the reliability of six commercial SERS substrates. Plasmonics, 15(5), 1323–1332.

5. Zhang, Y. (2020). Dataset concerning plasmonic thermal destruction of murine melanoma by gold nanoparticles obtained by green chemistry. Data in Brief, 30, 105370.